Statistically significant but clinically unimportant: a systematic review and meta-analysis of the analgesic benefits of erector spinae plane block following breast cancer surgery
- PMID: 33168651
- DOI: 10.1136/rapm-2020-101917
Statistically significant but clinically unimportant: a systematic review and meta-analysis of the analgesic benefits of erector spinae plane block following breast cancer surgery
Abstract
The novel erector spinae plane block (ESPB) has been reported to provide important postoperative analgesic benefits following a variety of truncal and abdominal surgical procedures. However, evidence of its analgesic efficacy following breast cancer surgery, compared with parenteral analgesia, is unclear. This meta-analysis evaluates the analgesic benefits of adding ESPB to parenteral analgesia following breast cancer surgery.Databases were searched for breast tumor resection trials comparing ESPB to parenteral analgesia. The two co-primary outcomes examined were 24-hour postoperative oral morphine equivalent consumption and area-under-curve of rest pain scores. We considered reductions equivalent to 3.3 cm.h and 30 mg oral morphine in the first 24 hours postoperatively for the two co-primary outcomes, respectively, to be clinically important. We also assessed opioid-related side effects and long-term outcomes, including health-related quality of life, persistent postsurgical pain and opioid dependence. Results were pooled using random effects modeling.Twelve trials (699 patients) were analyzed. Moderate quality evidence suggested that ESPB decreased 24-hour morphine consumption and area-under-curve of rest pain by a mean difference (95% CI) of -17.60 mg (-24.27 to -10.93) and -2.74 cm.h (-3.09 to -2.39), respectively; but these differences were not clinically important. High-quality evidence suggested that ESPB decreased opioid-related side effects compared with parenteral analgesia by an OR (95% CI) of 0.43 (0.28 to 0.66). None of the studies evaluated long-term block benefits.Adding ESPB to parenteral analgesia provides statistically significant but clinically unimportant short-term benefits following breast cancer surgery. Current evidence does not support routine use of ESPB. Given the very modest short-term benefits and risk of complications, the block should be considered on a case-by-case basis.
Keywords: analgesia; nerve block; pain; pain management; postoperative.
© American Society of Regional Anesthesia & Pain Medicine 2021. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: None declared.
Comment in
-
Erector spinae plane block: did low p values overstate the evidence against the null hypothesis and distract us from clinically unimportant effects?Reg Anesth Pain Med. 2021 Jan;46(1):1-2. doi: 10.1136/rapm-2020-102152. Epub 2020 Nov 9. Reg Anesth Pain Med. 2021. PMID: 33168650 No abstract available.
-
Minimal clinically important difference: a context-specific metric.Reg Anesth Pain Med. 2021 Oct;46(10):933-934. doi: 10.1136/rapm-2020-102330. Epub 2020 Dec 23. Reg Anesth Pain Med. 2021. PMID: 33361313 No abstract available.
-
Reply: minimal clinically important difference: a context-specific metric.Reg Anesth Pain Med. 2021 Oct;46(10):934. doi: 10.1136/rapm-2020-102372. Epub 2020 Dec 23. Reg Anesth Pain Med. 2021. PMID: 33361314 No abstract available.
-
In reply to Schnabel et al.Reg Anesth Pain Med. 2022 Jan;47(1):72-73. doi: 10.1136/rapm-2021-102725. Epub 2021 Mar 31. Reg Anesth Pain Med. 2022. PMID: 33790045 No abstract available.
-
'It's not over until it's over'.Reg Anesth Pain Med. 2022 Jan;47(1):71-72. doi: 10.1136/rapm-2021-102663. Epub 2021 Mar 31. Reg Anesth Pain Med. 2022. PMID: 33790047 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical